Treatment of dextran sodium sulfate (DSS)-induced colitis in mice with TQ suppresses malondialdehyde (MDA) levels and myeloperoxidase (MPO) activity with concomitant increase in glutathione levels indicating improvement in colitis-associated tissue damage [36]. The gene discussed is MPO; the disease is colitis.